Rhinitis Allergic Seasonal
📧 Sign up to get email alerts when something new happens for Rhinitis Allergic Seasonal.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-10EMA Authorised: Desloratadine Actavis (desloratadine) — Actavis Group PTC ehf
Authorised Desloratadine Actavis (desloratadine) for allergic rhinitis and urticaria in the EU.
-
EMA approval · 2026-07-10EMA Authorised: Desloratadine ratiopharm (desloratadine) — Ratiopharm GmbH
Authorised desloratadine product from Ratiopharm (desloratadine) for allergic rhinitis and urticaria indications in the EU.
-
EMA approval · 2022-06-24EMA Authorised: Desloratadine ratiopharm (desloratadine) — Ratiopharm GmbH
Authorised desloratadine product Desloratadine ratiopharm by Ratiopharm GmbH for allergic rhinitis and urticaria indications.
-
EMA approval · 2022-06-09EMA Authorised: Dasselta (desloratadine) — Krka, d.d., Novo mesto
Dasselta (desloratadine) by Krka has been authorised for allergic rhinitis (perennial and seasonal) and urticaria in the EU.